Is hospital-in-the-home (HITH) treatment of bacterial endocarditis safe and effective?

J. H. McMahon, Jason M O'keeffe, the Victorian Hith Outcomes Study Group, M. L. Grayson

Research output: Contribution to journalArticleResearchpeer-review

21 Citations (Scopus)


Although serious infections such as bacterial endocarditis (BE) are being increasingly treated with parenteral antibiotics via Hospital-in-the-Home (HITH) programmes in Australia, there are few published data to confirm the safety and efficacy of this treatment modality, especially among patients with BE due to pathogens other than streptococci. In a 12-month prospective, multi-site study we assessed HITH treatment outcomes for all cases of BE. Among the 40 BE cases (29 'definite', 11 'possible'; Duke criteria) caused by a range of pathogens (16 staphylococci spp., 11 streptococci, 4 other, 9 culture-negative), cure was achieved in 37 (93%) cases. BE due to Staphylococcus aureus was significantly associated with an inferior outcome (p =0.046). Adverse events were relatively common (9/40), but most were not severe and were managed with continuation of HITH care. BE can be safely managed via HITH, but particular care in patient selection is necessary, especially for cases due to S. aureus.
Original languageEnglish
Pages (from-to)40-43
Number of pages4
JournalScandinavian Journal of Infectious Diseases
Issue number1
Publication statusPublished - 2008


  • Adult Aged Anti-Bacterial Agents/*therapeutic use Australia Endocarditis, Bacterial/*drug therapy Female *Home Care Services Humans Male Middle Aged Patient Selection Pilot Projects Prospective Studies

Cite this